12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet

Verify with CMS →

oxymorphone hydrochloride

RxCUI: 977894

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
6.2%
Plan Coverage
316
Plans Covering
T3.1
Avg Tier
0%
Prior Auth Required

What the CMS Formulary Data Shows for 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet

Per the CMS 2026 Part D formulary file, 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet (RxNorm concept RXCUI 977894, generic name oxymorphone hydrochloride) appears on 21 distinct formulary files spanning 316 Medicare Part D plan offerings - 6.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.1.

Real-world access to 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 85.7% apply quantity limits.

Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet today.

Coverage Details

Formularies covering
21
Plans covering
316
Coverage rate
6.2%
Tier range
Tier 1 – Tier 4
Average tier
Tier 3, Preferred Brand

Restrictions

Prior authorization required
0% of formularies
Step therapy required
0% of formularies
Quantity limits
85.7% of formularies

Tier Distribution Across Plans

13 plans
Tier 1, Preferred Generic
9 plans
Tier 2, Generic
2 plans
Tier 3, Preferred Brand
76 plans
Tier 4, Non-Preferred

Standalone Drug Plans (PDP) Covering 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet

9 standalone prescription drug plans include this drug.

Plan Insurer Tier PA ST Premium States
HealthSpring Assurance Rx (PDP) MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY T4 No No $0 -
HealthSpring Assurance Rx (PDP) MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY T4 No No $0 -
HealthSpring Assurance Rx (PDP) MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY T4 No No $0 -
HealthSpring Assurance Rx (PDP) MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY T4 No No $0 -
HealthSpring Assurance Rx (PDP) MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY T4 No No $0 -
HealthSpring Assurance Rx (PDP) MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY T4 No No $0 -
HealthSpring Assurance Rx (PDP) MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY T4 No No $0 -
HealthSpring Assurance Rx (PDP) MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY T4 No No $0 -
HealthSpring Assurance Rx (PDP) MEDCO CONTAINMENT LIFE AND MEDCO CONTAINMENT NY T4 No No $0 -

Medicare Advantage Plans (MA-PD) Covering 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet

91 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
PHP (HMO C-SNP) AIDS HEALTHCARE FOUNDATION T1 No $0 CA
VNS Health Total (HMO D-SNP) VNS CHOICE T1 No $0 NY
CalOptima Health OneCare Complete (HMO D-SNP) ORANGE COUNTY HEALTH AUTHORITY T1 No $0 CA
Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 No $0 PA
Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 No $0 PA
Highmark Health Options Duals (HMO D-SNP) HIGHMARK HEALTH OPTIONS WEST VIRGINIA INC. T1 No $0 WV
Highmark Health Options Duals (HMO D-SNP) HIGHMARK BCBSD, INC. T1 No $0 DE
Gold Dialysis & Kidney Complete (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T1 No $4.80 FL
Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 No $13.10 PA
Gold Dialysis & Kidney Complete (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T1 No $17.00 AZ
Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 No $17.60 PA
Highmark Health Options Duals Select (HMO D-SNP) HIGHMARK BCBSD, INC. T1 No $31.20 DE
VNS Health EasyCare Plus (HMO D-SNP) VNS CHOICE T1 No $51.60 NY
Gold Heart & Diabetes (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T2 No $0 FL
Gold Heart & Diabetes Complete (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T2 No $0 FL
Gold Dialysis & Kidney (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T2 No $0 FL
Gold Health (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T2 No $0 FL
Gold Dialysis & Kidney (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T2 No $0 FL
Gold Heart & Diabetes (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T2 No $0 AZ
Gold Dialysis & Kidney (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T2 No $0 AZ
Gold Heart & Diabetes (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T2 No $0 AZ
Gold Dialysis & Kidney (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T2 No $0 AZ
VillageCareMAX Medicare Health Advantage Plan (HMO D-SNP) VILLAGE SENIOR SERVICES CORPORATION T3 No $0 NY
VillageCareMAX Medicare Total Advantage Plan (HMO D-SNP) VILLAGE SENIOR SERVICES CORPORATION T3 No $0 NY
Medicare BlueEssential (PPO) EXCELLUS HEALTH PLAN, INC. T4 No $0 NY
Medicare BlueActive (PPO) EXCELLUS HEALTH PLAN, INC. T4 No $0 NY
Medicare BlueVital (PPO) EXCELLUS HEALTH PLAN, INC. T4 No $0 NY
Univera SeniorChoice Basic (HMO) EXCELLUS HEALTH PLAN, INC. T4 No $0 NY
Univera SeniorChoice Extra (HMO) EXCELLUS HEALTH PLAN, INC. T4 No $0 NY
Medicare Blue Choice Core (HMO) EXCELLUS HEALTH PLAN, INC. T4 No $0 NY
HAP Medicare Explore (PPO) ALLIANCE HEALTH AND LIFE INSURANCE COMPANY T4 No $0 MI
HAP Medicare Prime (PPO) ALLIANCE HEALTH AND LIFE INSURANCE COMPANY T4 No $0 MI
HAP Medicare Connect (HMO) HEALTH ALLIANCE PLAN OF MICHIGAN T4 No $0 MI
HAP Medicare Complete Duals (HMO D-SNP) HEALTH ALLIANCE PLAN OF MICHIGAN T4 No $0 MI
HAP Medicare Superior (HMO) HEALTH ALLIANCE PLAN OF MICHIGAN T4 No $0 MI
Henry Ford Select (HMO) HEALTH ALLIANCE PLAN OF MICHIGAN T4 No $0 MI
Univera Medicare Dual (HMO D-SNP) EXCELLUS HEALTH PLAN COMMUNITY CARE LLC T4 No $0 NY
Medicare Blue Dual (HMO D-SNP) EXCELLUS HEALTH PLAN COMMUNITY CARE LLC T4 No $0 NY
HealthSpring Preferred (HMO) BRAVO HEALTH PENNSYLVANIA, INC. T4 No $0 AZ
HealthSpring Alliance (HMO) BRAVO HEALTH PENNSYLVANIA, INC. T4 No $0 AZ
HealthSpring Preferred Savings (HMO) BRAVO HEALTH PENNSYLVANIA, INC. T4 No $0 AZ
HealthSpring Preferred Full Savings (HMO) BRAVO HEALTH PENNSYLVANIA, INC. T4 No $0 AZ
HealthSpring Preferred GA (HMO) HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. T4 No $0 GA
HealthSpring Preferred (HMO) HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. T4 No $0 GA
HealthSpring Preferred (HMO) HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. T4 No $0 GA
HealthSpring Preferred (HMO) HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. T4 No $0 GA
HealthSpring Preferred (HMO) HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. T4 No $0 GA
HealthSpring Preferred (HMO) HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. T4 No $0 GA
HealthSpring Preferred (HMO) HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. T4 No $0 GA
HealthSpring Preferred Savings (HMO) HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. T4 No $0 GA

Frequently Asked Questions

Is 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet covered by Medicare Part D?

Yes, 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet is covered by 316 Medicare Part D plans (6.2% of all Part D formularies).

What tier is 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet on Medicare Part D plans?

12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet averages Tier 3.1 across Part D plans, ranging from Tier 1 to Tier 4.

Does 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet require prior authorization?

0% of Part D formularies require prior authorization for 12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet. Step therapy: 0%. Quantity limits: 85.7%.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial